Study Stopped
Unable to recruit successfully
Non-Invasive Direct Current Stimulation for Cognition in Schizophrenia
1 other identifier
interventional
17
1 country
1
Brief Summary
This study proposes to assess the effect of trans-cranial direct current stimulation (tDCS) on cognitive control, working memory, functional, clinical, and cognitive outcomes in schizophrenia patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable schizophrenia
Started May 2016
Typical duration for not_applicable schizophrenia
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 5, 2016
CompletedFirst Posted
Study publicly available on registry
April 15, 2016
CompletedStudy Start
First participant enrolled
May 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2019
CompletedResults Posted
Study results publicly available
July 7, 2022
CompletedJuly 7, 2022
June 1, 2022
3.1 years
April 5, 2016
June 29, 2020
June 13, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Cognitive Control
The investigators will assess cognitive control using the Preparing to Overcome Prepotency (POP) task. The accuracy mean differences between the high and low control conditions will be used as dependent measures. The study is powered at 0.8 to observe a post-pre treatment improvement in cognitive control with a substantial effect size (d=0.56) compared to sham stimulation with effects relatively stable measured 2 months after baseline. The hypothesized effect size will be d=0.60.
Week 1
Working Memory
The investigators will assess working memory using a working memory task. The accuracy mean differences between the high and low control conditions will be used as dependent measures. The study is powered at 0.8 to observe a post-pre treatment improvement in cognitive control with a substantial effect size (d=0.56) compared to sham stimulation with effects relatively stable measured 2 months after baseline. The hypothesized effect size will be d=0.60.
Week 1
Secondary Outcomes (2)
Negative Symptoms
Week 1
Auditory Hallucinations
Week 1
Study Arms (2)
Active Stimulation
EXPERIMENTALActive stimulation group will receive 20 min of 2 mA direct current stimulation.
Sham Stimulation
SHAM COMPARATORThis will be an active sham involving brief (15 msec) low current (0.11 mA) pulses every 550 ms.
Interventions
Active stimulation group will receive 20 min of 2 mA direct current stimulation.
This will be an active sham involving brief (15 msec) low current (0.11 mA) pulses every 550 ms.
Eligibility Criteria
You may qualify if:
- Early course psychosis:
- DSM-V diagnosis of Schizophrenia, Schizoaffective disorder, or schizophreniform disorder.
- ages 18-50 years
- on stable doses of medication for at least one month
- not taking benzodiazepines or mood stabilizers.
- Mild to severe cognitive impairment in MATRICS Consensus Cognitive Battery (composite scores \< 40)
- Chronic psychosis:
- Same as early course psychosis but \>5 years of antipsychotic treatment
You may not qualify if:
- Diagnostic and Statistical Manual-Version V (DSM-V) diagnosis of mental retardation
- significant head injury
- medical illness affecting brain function or structure
- pregnancy or postpartum (\<6 weeks after delivery or miscarriage)
- significant neurologic disorder (e.g seizure disorder)
- inability to provide informed consent
- significant color blindness that affects task performance
- Comorbidity for DSM-V substance abuse disorder within the past one month
- Temporal relation between illness onset and head injury
- Taking benzodiazepines or mood stabilizers (lithium allowed)
- Positive drug screen (excluding THC at baseline)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Baylor College of Medicinelead
- Brain & Behavior Research Foundationcollaborator
Study Sites (1)
Baylor College of Medicine
Houston, Texas, 77030, United States
Related Publications (10)
Brunelin J, Mondino M, Gassab L, Haesebaert F, Gaha L, Suaud-Chagny MF, Saoud M, Mechri A, Poulet E. Examining transcranial direct-current stimulation (tDCS) as a treatment for hallucinations in schizophrenia. Am J Psychiatry. 2012 Jul;169(7):719-24. doi: 10.1176/appi.ajp.2012.11071091.
PMID: 22581236BACKGROUNDBrunoni AR, Nitsche MA, Bolognini N, Bikson M, Wagner T, Merabet L, Edwards DJ, Valero-Cabre A, Rotenberg A, Pascual-Leone A, Ferrucci R, Priori A, Boggio PS, Fregni F. Clinical research with transcranial direct current stimulation (tDCS): challenges and future directions. Brain Stimul. 2012 Jul;5(3):175-195. doi: 10.1016/j.brs.2011.03.002. Epub 2011 Apr 1.
PMID: 22037126BACKGROUNDCho RY, Konecky RO, Carter CS. Impairments in frontal cortical gamma synchrony and cognitive control in schizophrenia. Proc Natl Acad Sci U S A. 2006 Dec 26;103(52):19878-83. doi: 10.1073/pnas.0609440103. Epub 2006 Dec 14.
PMID: 17170134BACKGROUNDGreen MF. What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry. 1996 Mar;153(3):321-30. doi: 10.1176/ajp.153.3.321.
PMID: 8610818BACKGROUNDLisman J, Buzsaki G. A neural coding scheme formed by the combined function of gamma and theta oscillations. Schizophr Bull. 2008 Sep;34(5):974-80. doi: 10.1093/schbul/sbn060. Epub 2008 Jun 16.
PMID: 18559405BACKGROUNDMondino M, Brunelin J, Palm U, Brunoni AR, Poulet E, Fecteau S. Transcranial Direct Current Stimulation for the Treatment of Refractory Symptoms of Schizophrenia. Current Evidence and Future Directions. Curr Pharm Des. 2015;21(23):3373-83. doi: 10.2174/1381612821666150619093648.
PMID: 26088110BACKGROUNDStagg CJ, Best JG, Stephenson MC, O'Shea J, Wylezinska M, Kincses ZT, Morris PG, Matthews PM, Johansen-Berg H. Polarity-sensitive modulation of cortical neurotransmitters by transcranial stimulation. J Neurosci. 2009 Apr 22;29(16):5202-6. doi: 10.1523/JNEUROSCI.4432-08.2009.
PMID: 19386916BACKGROUNDStagg CJ, Nitsche MA. Physiological basis of transcranial direct current stimulation. Neuroscientist. 2011 Feb;17(1):37-53. doi: 10.1177/1073858410386614.
PMID: 21343407BACKGROUNDUhlhaas PJ, Singer W. Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci. 2010 Feb;11(2):100-13. doi: 10.1038/nrn2774.
PMID: 20087360BACKGROUNDVolk DW, Lewis DA. Prefrontal cortical circuits in schizophrenia. Curr Top Behav Neurosci. 2010;4:485-508. doi: 10.1007/7854_2010_44.
PMID: 21312410BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
Despite concerted and exhaustive subject recruitment efforts, the total number of patients completing the protocol was minimal. As such the sample size was inadequate for deriving any meaningful descriptive statistics or statistical comparisons.
Results Point of Contact
- Title
- Raymond Cho
- Organization
- Baylor College of Medicine
Study Officials
- PRINCIPAL INVESTIGATOR
Raymond Cho, MD
Baylor College of Medicine
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- LTE60
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 5, 2016
First Posted
April 15, 2016
Study Start
May 1, 2016
Primary Completion
June 1, 2019
Study Completion
June 1, 2019
Last Updated
July 7, 2022
Results First Posted
July 7, 2022
Record last verified: 2022-06
Data Sharing
- IPD Sharing
- Will share
Data will be open to sharing after primary findings of study have been published.